1.
    发明专利
    未知

    公开(公告)号:DE3884672T2

    公开(公告)日:1994-04-28

    申请号:DE3884672

    申请日:1988-02-16

    Applicant: SCLAVO SPA

    Abstract: The specification relates to a synthetic peptide converted into a salt comprising one or more amine groups and capable of potentiating in vivo the primary and secondary antibody response to thymo-dependent and thymo-independent antigens having low immunogenicity. Injectable preparations comprising a solution of the peptide in a pharmacologically acceptable solvent are particularly useful as adjuvants in therapy.

    3.
    发明专利
    未知

    公开(公告)号:AT63749T

    公开(公告)日:1991-06-15

    申请号:AT86830299

    申请日:1986-10-17

    Applicant: SCLAVO SPA

    Abstract: Synthetic peptide with human interleukin 1 acti­vity, which peptide can be used as a stimulant of the immune functions and can be defined by the general formula:    Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys-X      (I)where:Val = L-valine; Gln = L-glutamine; Gly = glycine; Glu = L-glutamic acid; Ser = L-serine; Asn = L-asparagine; Asp = L-aspartic acid; Lys = L-lysine; X = cysteine (Cys), OH, NH₂, a benzyl ester or an alkyl ester group having a number of carbon atoms from 1 to 7.

    4.
    发明专利
    未知

    公开(公告)号:AT95422T

    公开(公告)日:1993-10-15

    申请号:AT88830056

    申请日:1988-02-16

    Applicant: SCLAVO SPA

    Abstract: The specification relates to a synthetic peptide converted into a salt comprising one or more amine groups and capable of potentiating in vivo the primary and secondary antibody response to thymo-dependent and thymo-independent antigens having low immunogenicity. Injectable preparations comprising a solution of the peptide in a pharmacologically acceptable solvent are particularly useful as adjuvants in therapy.

    8.
    发明专利
    未知

    公开(公告)号:DE3679396D1

    公开(公告)日:1991-06-27

    申请号:DE3679396

    申请日:1986-10-17

    Applicant: SCLAVO SPA

    Abstract: Synthetic peptide with human interleukin 1 acti­vity, which peptide can be used as a stimulant of the immune functions and can be defined by the general formula:    Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys-X      (I)where:Val = L-valine; Gln = L-glutamine; Gly = glycine; Glu = L-glutamic acid; Ser = L-serine; Asn = L-asparagine; Asp = L-aspartic acid; Lys = L-lysine; X = cysteine (Cys), OH, NH₂, a benzyl ester or an alkyl ester group having a number of carbon atoms from 1 to 7.

Patent Agency Ranking